PANDER binds to the liver cell membrane and inhibits insulin signaling in HepG2 cells

FEBS Letters

Volumn 583, Issue 18, 2009, Pages 3009-3015

  Yang, Jichun ^a   Wang, Chunjiong ^a   Li, Jing ^a   Burkhardt, Brant R ^b   Robert Cooperman, Claudia E ^b   Wilson, Camella ^b   Gao, Zhiyong ^b   Wolf, Bryan A ^b  

^a PEKING UNIVERSITY   (China)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Cytokine; Insulin resistance; Insulin signaling pathway; PANDER

Indexed keywords

CYTOKINE; INSULIN; INSULIN RECEPTOR; IODINE 125; PANCREATIC DERIVED FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LIVER CELL MEMBRANE; MEMBRANE BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN TARGETING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BINDING, COMPETITIVE; CELL LINE, TUMOR; CELL MEMBRANE; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INSULIN; LIVER; MICE; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION;

EID: 69949174739     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.08.008     Document Type: Article

References (32)

1. Wild S., Roglic G., Green A., Sicree R., and King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
2. Schinner S., Scherbaum W.A., Bornstein S.R., and Barthel A. Molecular mechanisms of insulin resistance. Diabetes Med. 22 (2005) 674-682
3. Dong X., Park S., Lin X., Copps K., Yi X., and White M.F. Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth. J. Clin. Invest. 116 (2006) 101-114
4. Gribble F.M. Metabolism: A higher power for insulin. Nature 434 (2005) 965-966
5. Shulman G.I. Cellular mechanisms of insulin resistance. J. Clin. Invest. 106 (2000) 171-176
6. Kim J.H., Bachmann R.A., and Chen J. Interleukin-6 and insulin resistance. Vitam. Horm. 80 (2009) 613-633
7. Banerjee R.R., Rangwala S.M., Shapiro J.S., Rich A.S., Rhoades B., Qi Y., Wang J., Rajala M.W., Pocai A., Scherer P.E., Steppan C.M., Ahima R.S., Obici S., Rossetti L., and Lazar M.A. Regulation of fasted blood glucose by resistin. Science 303 (2004) 1195-1198
8. Muse E.D., Obici S., Bhanot S., Monia B.P., McKay R.A., Rajala M.W., Scherer P.E., and Rossetti L. Role of resistin in diet-induced hepatic insulin resistance. J. Clin. Invest. 114 (2004) 232-239
9. Barnes K.M., and Miner J.L. Role of resistin in insulin sensitivity in rodents and humans. Curr. Protein Pept. Sci. 10 (2009) 96-107
10. Barbuzza O., Guarneri F., Galtieri G., Gangemi S., and Vaccaro M. Protein contact dermatitis and allergic asthma caused by Anisakis simplex. Contact Dermatitis 60 (2009) 239-240
11. Zhu Y., Xu G., Patel A., McLaughlin M.M., Silverman C., Knecht K., Sweitzer S., Li X., McDonnell P., Mirabile R., Zimmerman D., Boyce R., Tierney L.A., Hu E., Livi G.P., Wolf B., Abdel-Meguid S.S., Rose G.D., Aurora R., Hensley P., Briggs M., and Young P.R. Cloning, expression, and initial characterization of a novel cytokine-like gene family. Genomics 80 (2002) 144-150
12. Yang J., Gao Z., Robert C.E., Burkhardt B.R., Gaweska H., Wagner A., Wu J., Greene S.R., Young R.A., and Wolf B.A. Structure-function studies of PANDER, an islet specific cytokine inducing cell death of insulin-secreting beta cells. Biochemistry 44 (2005) 11342-11352
13. Cao X., Yang J., Burkhardt B.R., Gao Z., Wong R.K., Greene S.R., Wu J., and Wolf B.A. Effects of overexpression of pancreatic derived factor (FAM3B) in isolated mouse islets and insulin-secreting betaTC3 cells. Am. J. Physiol. Endocrinol. Metab. 289 (2005) E543-E550
14. Burkhardt B.R., Yang M.C., Robert C.E., Greene S.R., McFadden K.K., Yang J., Wu J., Gao Z., and Wolf B.A. Tissue-specific and glucose-responsive expression of the pancreatic derived factor (PANDER) promoter. Biochim. Biophys. Acta. 1730 (2005) 215-225
15. Yang J., Robert C.E., Burkhardt B.R., Young R.A., Wu J., Gao Z., and Wolf B.A. Mechanisms of glucose-induced secretion of pancreatic-derived factor (PANDER or FAM3B) in pancreatic beta-cells. Diabetes 54 (2005) 3217-3228
16. Burkhardt B.R., Cook J.R., Young R.A., and Wolf B.A. PDX-1 interaction and regulation of the Pancreatic Derived Factor (PANDER, FAM3B) promoter. Biochim. Biophys. Acta 1779 (2008) 645-651
17. Wang O., Cai K., Pang S., Wang T., Qi D., Zhu Q., Ni Z., and Le Y. Mechanisms of glucose-induced expression of pancreatic-derived factor in pancreatic beta-cells. Endocrinology 149 (2008) 672-680
18. Borge Jr. P.D., and Wolf B.A. Insulin receptor substrate 1 regulation of sarco-endoplasmic reticulum calcium ATPase 3 in insulin-secreting beta-cells. J. Biol. Chem. 278 (2003) 11359-11368
19. Papotti M., Ghe C., Cassoni P., Catapano F., Deghenghi R., Ghigo E., and Muccioli G. Growth hormone secretagogue binding sites in peripheral human tissues. J. Clin. Endocrinol. Metab. 85 (2000) 3803-3807
20. Muccioli G., Ghe C., Ghigo M.C., Papotti M., Arvat E., Boghen M.F., Nilsson M.H., Deghenghi R., Ong H., and Ghigo E. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland. J. Endocrinol. 157 (1998) 99-106
21. Senn J.J., Klover P.J., Nowak I.A., and Mooney R.A. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes 51 (2002) 3391-3399
22. 2+ homeostasis and insulin secretion. J. Biol. Chem. 274 (1999) 18067-18074
23. Konrad R.J., Dean R.M., Young R.A., Billings P.C., and Wolf B.A. Glucose-induced tyrosine phosphorylation of p125 in beta cells and pancreatic islets. A novel proximal signal in insulin secretion. J. Biol. Chem. 271 (1996) 24179-24186
24. Cao X., Gao Z., Robert C.E., Greene S., Xu G., Xu W., Bell E., Campbell D., Zhu Y., Young R., Trucco M., Markmann J.F., Naji A., and Wolf B.A. Pancreatic-derived factor (FAM3B), a novel islet cytokine, induces apoptosis of insulin-secreting beta-cells. Diabetes 52 (2003) 2296-2303
25. Kamada Y., Takehara T., and Hayashi N. Adipocytokines and liver disease. J. Gastroenterol. 43 (2008) 811-822
26. Otabe S., Yuan X., Fukutani T., Wada N., Hashinaga T., Nakayama H., Hirota N., Kojima M., and Yamada K. Overexpression of human adiponectin in transgenic mice results in suppression of fat accumulation and prevention of premature death by high-calorie diet. Am. J. Physiol. Endocrinol. Metab. 293 (2007) E210-E218
27. Sun Q., Li L., Li R., Yang M., Liu H., Nowicki M.J., Zong H., Xu J., and Yang G. Overexpression of visfatin/PBEF/Nampt alters whole-body insulin sensitivity and lipid profile in rats. Ann. Med. 41 (2009) 311-320
28. Steppan C.M., Wang J., Whiteman E.L., Birnbaum M.J., and Lazar M.A. Activation of SOCS-3 by resistin. Mol. Cell Biol. 25 (2005) 1569-1575
29. Larsen C.M., Faulenbach M., Vaag A., Volund A., Ehses J.A., Seifert B., Mandrup-Poulsen T., and Donath M.Y. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 356 (2007) 1517-1526
30. Kahn S.E., D'Alessio D.A., Schwartz M.W., Fujimoto W.Y., Ensinck J.W., Taborsky Jr. G.J., and Porte Jr. D. Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes 39 (1990) 634-638
31. Kautzky-Willer A., Thomaseth K., Ludvik B., Nowotny P., Rabensteiner D., Waldhausl W., Pacini G., and Prager R. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes. Diabetes 46 (1997) 607-614
32. Gong W., Liu Z.H., Zeng C.H., Peng A., Chen H.P., Zhou H., and Li L.S. Amylin deposition in the kidney of patients with diabetic nephropathy. Kidney Int. 72 (2007) 213-218